Takeda Pharmaceutical Company Limited
A global, R&D-driven biopharmaceutical company discovering and delivering treatments.
4502 | T
Overview
Corporate Details
- ISIN(s):
- JP3463000004 (+1 more)
- LEI:
- Country:
- Japan
- Address:
- 大阪市中央区道修町四丁目１番１号
- Website:
- https://www.takeda.com/
- Sector:
- Manufacturing
Description
Takeda Pharmaceutical Company Limited is a global, patient-focused, and R&D-driven biopharmaceutical company dedicated to discovering and delivering life-transforming treatments. The company's mission is to provide better health for people and a brighter future for the world. Its core therapeutic areas of focus include oncology, rare diseases, neuroscience, and gastroenterology. Takeda also invests significantly in Plasma-Derived Therapies and Vaccines. The company's operations encompass the entire pharmaceutical value chain, from translating science into highly innovative medicines through research and development to manufacturing, sales, and marketing on a global scale.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-06-29 09:06 |
確認書
|
Japanese | ZIP • 9.4 KB | ||
| 2022-06-29 09:06 |
有価証券報告書－第145期(令和3年4月1日－令和4年3月31日)
|
Japanese | ZIP • 2.9 MB | ||
| 2022-02-10 05:00 |
四半期報告書－第145期第3四半期(令和3年10月1日－令和3年12月31日)
|
Japanese | ZIP • 563.2 KB | ||
| 2021-11-05 05:06 |
四半期報告書－第145期第2四半期(令和3年7月1日－令和3年9月30日)
|
Japanese | ZIP • 557.3 KB | ||
| 2021-08-06 08:09 |
四半期報告書－第145期第1四半期(令和3年4月1日－令和3年6月30日)
|
Japanese | ZIP • 453.8 KB | ||
| 2021-06-29 07:32 |
確認書
|
Japanese | ZIP • 9.4 KB | ||
| 2021-06-29 07:31 |
内部統制報告書－第144期(令和2年4月1日－令和3年3月31日)
|
Japanese | ZIP • 29.1 KB | ||
| 2021-06-29 07:30 |
有価証券報告書－第144期(令和2年4月1日－令和3年3月31日)
|
Japanese | ZIP • 2.9 MB | ||
| 2021-02-12 03:17 |
四半期報告書－第144期第3四半期(令和2年10月1日－令和2年12月31日)
|
Japanese | ZIP • 568.5 KB | ||
| 2020-11-10 05:14 |
四半期報告書－第144期第2四半期(令和2年7月1日－令和2年9月30日)
|
Japanese | ZIP • 556.6 KB | ||
| 2020-08-12 06:13 |
四半期報告書－第144期第1四半期(令和2年4月1日－令和2年6月30日)
|
Japanese | ZIP • 447.5 KB | ||
| 2020-06-24 08:07 |
有価証券報告書－第143期(平成31年4月1日－令和2年3月31日)
|
Japanese | ZIP • 2.8 MB | ||
| 2020-02-13 04:12 |
四半期報告書－第143期第3四半期(令和1年10月1日－令和1年12月31日)
|
Japanese | ZIP • 524.5 KB | ||
| 2019-11-12 05:43 |
四半期報告書－第143期第2四半期(2019/07/01－2019/09/30)
|
Japanese | ZIP • 483.7 KB | ||
| 2019-08-09 06:30 |
四半期報告書－第143期第1四半期(2019/04/01－2019/06/30)
|
Japanese | ZIP • 408.0 KB |
Automate Your Workflow. Get a real-time feed of all Takeda Pharmaceutical Company Limited filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Takeda Pharmaceutical Company Limited
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Takeda Pharmaceutical Company Limited via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
